|
Market Closed -
Euronext Paris
11:55:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 18.60 EUR | +3.91% |
|
+5.68% | -38.61% |
| 09-17 | Boiron SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-22 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 323M 362M 299M 272M 512M 34.33B 520M 3.6B 1.41B 17.92B 1.36B 1.33B 57.2B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 275M 309M 254M 232M 436M 29.24B 443M 3.07B 1.2B 15.27B 1.16B 1.13B 48.73B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
19.96% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| BOI | Real-time | |
CBOE
| BOIp | Real-time | |
Boerse Muenchen
| BON | Real-time | |
Börse Stuttgart
| BON | Delayed | |
Deutsche Boerse AG
| BON | Delayed | |
CBOE
| 0DTF | Real-time |
| 1 day | +3.91% | ||
| 1 week | +5.68% | ||
| Current month | -7.00% | ||
| 1 month | -26.19% | ||
| 3 months | -30.60% | ||
| 6 months | -26.19% | ||
| Current year | -38.61% |
| 1 week | 16.9 | 19.5 | |
| 1 month | 16.9 | 21.5 | |
| Current year | 16.9 | 30.95 | |
| 1 year | 16.9 | 32.25 | |
| 3 years | 16.9 | 43.96 | |
| 5 years | 16.9 | 56.5 | |
| 10 years | 16.9 | 92.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 2024-12-31 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 2011-06-30 |
| Director/Board Member | 54 | 2010-03-09 | |
| Director/Board Member | 51 | 2013-05-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/29/23 | Sell | Director | 198,664 | 1.1323% | ||
| 10/29/23 | Sell | Director | 462,964 | 2.6387% | ||
| 10/29/23 | Sell | Director | 4,748 | 0.0271% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.91% | +5.68% | -32.36% | -64.57% | 363M | ||
| +0.43% | +6.59% | +56.57% | +106.64% | 1,120B | ||
| +0.90% | -2.25% | +32.26% | +63.73% | 616B | ||
| +0.71% | +3.24% | +24.33% | +91.33% | 504B | ||
| -0.13% | +5.98% | +33.66% | +50.18% | 367B | ||
| +0.52% | +0.24% | +72.13% | +40.11% | 360B | ||
| -0.95% | +4.70% | +19.65% | +42.71% | 288B | ||
| -1.98% | +3.73% | -0.89% | +10.43% | 258B | ||
| -0.35% | +4.25% | +44.74% | +52.06% | 234B | ||
| -0.75% | +3.32% | +27.18% | +94.07% | 194B | ||
| Average | +0.23% | +3.82% | +27.73% | +48.67% | 394.13B | |
| Weighted average by Cap. | +0.13% | +3.83% | +39.33% | +71.81% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 547M 451M 410M 772M 51.83B 785M 5.43B 2.13B 27.06B 2.05B 2B 86.36B | 501M 562M 463M 422M 794M 53.27B 807M 5.58B 2.19B 27.81B 2.11B 2.06B 88.76B |
| Net income | 11.34M 12.72M 10.48M 9.54M 17.96M 1.21B 18.26M 126M 49.49M 629M 47.62M 46.61M 2.01B | 32.64M 36.62M 30.18M 27.47M 51.72M 3.47B 52.58M 364M 143M 1.81B 137M 134M 5.78B |
| Net Debt | -49.74M -55.8M -45.99M -41.86M -78.8M -5.29B -80.12M -554M -217M -2.76B -209M -204M -8.81B | -47.86M -53.69M -44.25M -40.28M -75.82M -5.09B -77.09M -533M -209M -2.66B -201M -197M -8.48B |
Employees
2,623
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | €18.60 | +3.91% | 9,099 |
| 26-10-15 | €17.90 | -0.56% | 5,955 |
| 26-10-14 | €18.00 | +6.51% | 4,223 |
| 26-10-13 | €16.90 | -2.03% | 13,940 |
| 26-10-12 | €17.25 | -1.99% | 7,127 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
Select your edition
All financial news and data tailored to specific country editions

















